Skip to main content

Table 2 Patient characteristics

From: Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety

Patient

Age

Sex

ECOG

Location

Lymph nodes

1

62

M

1

Head

N1

2

79

F

1

Head & Body

N1

3

Withdrew before completing radiation

4

Screening failure due to metastatic disease

5

74

M

1

Body

N1

6

50

M

1

Body

N0

7

63

F

0

Head

N1

8

56

F

1

Head

N1

9

63

M

1

Head

N0

10

76

M

1

Head

N1

11

Screening failure due to elevated liver function.

12

Screening failure due to inability to place fiducials.

13

57

F

1

Head

N0

14

62

F

1

Head

N0